Lecture Preview | Fluorescence Analysis of Breast Cancer Precision Medicine

Release time:2025/10/15

Lecture time

October 17, 2025 16:00-17:30


Lecture location

Conference Room 402, Building 5, Jinfeng Laboratory


Lecture title: Fluorescence analysis of breast cancer precision medicine


Introduction to the speaker

picture



Gao Mingxuan , born in June 1987, Doctor of Science, Assistant Director/Professor of the Clinical Medical Research Center of the First Affiliated Hospital of Army Medical University, doctoral supervisor, New Chongqing Young Innovative Talent, and reserve candidate for Chongqing’s academic and technical leader. Research mainly focuses on the application of functionalized fluorescent nanomaterials in the early diagnosis and treatment of breast cancer. In recent years, he has published more than 40 SCI papers such as J. Am. Chem. Soc., Adv. Sci., ACS Nano, Anal. Chem., etc., and obtained 5 patent authorizations from China and the United States. Hosted 8 projects of the National Natural Science Foundation of China, the National Key Research and Development Plan of the Ministry of Science and Technology, and provincial and ministerial/military projects. He serves on the youth editorial board of magazines such as "interdisciplinary medicine" and "International Journal of Laboratory Medicine".


Lecture Introduction

In the era of precision oncology, early diagnosis and treatment of breast cancer have greatly improved the quality of life of breast cancer patients, which is inseparable from the rapid development of chemical and biological sensing technologies. Fluorescence analysis technology based on peripheral blood biopsy can effectively make up for some "bottleneck" problems in the precise diagnosis and treatment of breast cancer. In view of this, the research group has carried out a series of research work in the past five years around the development of fluorescence analysis methods for breast cancer and the clinical needs for early diagnosis of breast cancer: 1) Proposed a restricted reaction strategy using the nucleic acid structure as a thermodynamic limiter ; 2) Construct tandem multi-level hierarchical nucleic acid detection technology ; 3) Develop clinically available rapid testing technology through prospective clinical research.

Everyone is welcome to actively participate